A Randomized, Placebo-Controlled Trial of the Efficacy and Safety of Pregabalin in the Treatment of Subjects With Peripheral Neuropathic Pain.

Trial Profile

A Randomized, Placebo-Controlled Trial of the Efficacy and Safety of Pregabalin in the Treatment of Subjects With Peripheral Neuropathic Pain.

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Apr 2011

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Neuropathic pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Dec 2010 256 patients received treatment in the single-blind phase, and 157 were randomised in the double-blind phase.
    • 20 Dec 2010 Primary endpoint 'Pain-intensity' has been met
    • 09 Jun 2009 Actual number of patients (405) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top